Together, these results indicate that DOCK2 expression is downregulated in peripheral blood cells of patients with severe COVID-19, especially in young patients, and that the risk variant may contribute to severe COVID-19 by suppressing expression of DOCK2. The gene discussed is DOCK2; the disease is COVID-19.